XENAZINE Side Effects

7023447-6 | No Adverse Event
on Sep 13, 2010 Male patient from UNITED STATES , weighting 172.0 lb, was diagnosed with huntington's disease (What is huntington's disease?) and was treated with Xenazine (View Usage). Patient experienced the following unwanted or unexpected effects: no adverse event. Xenazine dosage: Df.

6988280-X | Somnolence, Tardive Dyskinesia
Patient was taking Xenazine (View Usage). Patient had the following side effects: somnolence, tardive dyskinesia on Aug 19, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 130.0 lb, was diagnosed with huntington's disease (What is huntington's disease?) and. Xenazine dosage: 25 Mg Qam, 37.5 Mg Qpm Oral. During the same period patient was treated with LEXAPRO (View Lexapro Review and Lexapro Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ).

6940563-5 | Acute Respiratory Distress Syndrome, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Cholangitis Acute, Jaundice, Pyrexia, Vomiting
Adverse event was reported on Aug 13, 2010 by a Female patient taking Xenazine (View Usage) (Dosage: (12.t Mg Qam And 25 Mg Qpm; Total Daily Dose 37.5 Mg Oral), (12.5 Mg Bid Oral)) was diagnosed with cerebral palsy, dystonia (What is dystonia?) and. Location: UNITED STATES , 18 years of age, After Xenazine was administered, patient had the following side effects: acute respiratory distress syndrome, alanine aminotransferase increased, aspartate aminotransferase increased, cholangitis acute, jaundice (What is jaundice?), pyrexia, vomiting. During the same period patient was treated with FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ), BACLOFEN (View Baclofen Review and Baclofen Label ), ATIVAN (View Ativan Review and Ativan Label ), PEPCID (View Pepcid Review and Pepcid Label ). Patient was hospitalized.

6902552-6 | Amnesia, Feeling Abnormal, Muscle Spasms, Psychotic Disorder, Rash Macular
on Jul 22, 2010 Female patient from UNITED STATES , weighting 134.0 lb, was diagnosed with dystonia (What is dystonia?) and was treated with Xenazine (View Usage). Patient experienced the following unwanted or unexpected effects: amnesia, feeling abnormal, muscle spasms, psychotic disorder (What is psychotic disorder?), rash macular. Xenazine dosage: (12.5 Mg Tid Oral). During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), TRIHEXYPHENIDYL HCL (View Trihexyphenidyl Hcl Review and Trihexyphenidyl Hcl Label ), NEXIUM (View Nexium Review and Nexium Label ), FLOVENT (View Flovent Review and Flovent Label ), PROAIR HFA (View Proair Hfa Review and Proair Hfa Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ).


6878134-1 | Middle Insomnia, Movement Disorder, Psychomotor Hyperactivity, Tremor
on Mar 10, 2010 Female patient from UNITED STATES , weighting 205.0 lb, was diagnosed with huntington's chorea and was treated with Xenazine (View Usage). Patient had the following side effects: middle insomnia, movement disorder (What is movement disorder?), psychomotor hyperactivity, tremor. Xenazine dosage: 12.5 Mg Tid Oral.

6878119-5 | Insomnia
Patient was taking Xenazine (View Usage). After Xenazine was administered, patient had the following side effects: insomnia on Mar 15, 2010 from UNITED STATES Additional patient health information: Male patient , 36 years of age, was diagnosed with huntington's chorea and. Xenazine dosage: 12.5 Mg Tid Oral, 25 Mg Tid Oral. During the same period patient was treated with TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ), KLONOPIN (View Klonopin Review and Klonopin Label ), ABILIFY (View Abilify Review and Abilify Label ), ARICEPT (View Aricept Review and Aricept Label ), NALTREXONE (View Naltrexone Review and Naltrexone Label ), COQ10 (View Coq10 Review and Coq10 Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ).

6878080-3 | Fall, Somnolence
Adverse event was reported on May 28, 2010 by a Female patient taking Xenazine (View Usage) (Dosage: (12.5 Mg Tid Oral), (12.5 Mg Bid Oral), (df)) was diagnosed with huntington's chorea and. Location: UNITED STATES , weighting 151.0 lb, Patient experienced the following unwanted or unexpected effects: fall (What is fall?), somnolence. During the same period patient was treated with AMANTADINE HCL (View Amantadine Hcl Review and Amantadine Hcl Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), CITALOPRAM (View Citalopram Review and Citalopram Label ), TOPAMAX (View Topamax Review and Topamax Label ), NAMENDA (View Namenda Review and Namenda Label ), BLACK COHOSH /01456805/ (View Black Cohosh /01456805/ Review and Black Cohosh /01456805/ Label ).

6878076-1 | Insomnia
on Mar 23, 2010 Female patient from UNITED STATES , weighting 144.0 lb, was diagnosed with huntington's chorea and was treated with Xenazine (View Usage). Patient had the following side effects: insomnia. Xenazine dosage: (12.5 Mg, Two Atblets In The Morning And One At Noon Oral), (12.5 Mg Bid Oral), (18.75 Mg, 12.5 Mg I. During the same period patient was treated with ATROVENT (View Atrovent Review and Atrovent Label ).

6876889-3 | Fatigue
on Apr 16, 2010 Female patient from UNITED STATES , 60 years of age, was diagnosed with huntington's chorea and was treated with Xenazine (View Usage). After Xenazine was administered, patient had the following side effects: fatigue. Xenazine dosage: (df).

6876886-8 | Weight Increased
Patient was taking Xenazine (View Usage). Patient experienced the following unwanted or unexpected effects: weight increased on Apr 20, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 132.3 lb, was diagnosed with huntington's chorea and. Xenazine dosage: (12.5 Mg Bid Oral). During the same period patient was treated with HOLDOL /00027401/ (View Holdol /00027401/ Review and Holdol /00027401/ Label ), AVAPRO (View Avapro Review and Avapro Label ).

6876878-9 | Excessive Eye Blinking
Adverse event was reported on Mar 24, 2010 by a Female patient taking Xenazine (View Usage) (Dosage: Half Of A 12.5 Mg Tablet Bid Oral) was diagnosed with huntington's chorea, tic (What is tic?) and. Location: UNITED STATES , weighting 60.00 lb, Patient had the following side effects: excessive eye blinking. During the same period patient was treated with PROLIXIN (View Prolixin Review and Prolixin Label ).

6876746-2 | Drooling, Fall, Hypotonia
on Apr 26, 2010 Male patient from UNITED STATES , child 6 years of age, was diagnosed with chorea and was treated with Xenazine (View Usage). After Xenazine was administered, patient had the following side effects: drooling, fall (What is fall?), hypotonia. Xenazine dosage: 50 Mg Qd. During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

6875902-7 | Depression
on Apr 13, 2010 Female patient from UNITED STATES , weighting 192.0 lb, was diagnosed with dyskinesia and was treated with Xenazine (View Usage). Patient experienced the following unwanted or unexpected effects: depression (What is depression?). Xenazine dosage: (25 Mg Tid Oral). During the same period patient was treated with ABILIFY (View Abilify Review and Abilify Label ).

6874643-X | Amnesia, Feeling Abnormal, Muscle Spasms, Rash Macular
Patient was taking Xenazine (View Usage). Patient had the following side effects: amnesia, feeling abnormal, muscle spasms, rash macular on Jul 12, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 106.0 lb, was diagnosed with dystonia (What is dystonia?) and. Xenazine dosage: (12.5 Mg Tid Oral). During the same period patient was treated with CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), LIPITOR (View Lipitor Review and Lipitor Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), TRIHEXYPHENIDYL HCL (View Trihexyphenidyl Hcl Review and Trihexyphenidyl Hcl Label ).

6874640-4 | Acute Respiratory Distress Syndrome, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Cholangitis Acute, Jaundice, Pyrexia, Vomiting
Adverse event was reported on Jul 13, 2010 by a Female patient taking Xenazine (View Usage) (Dosage: 12.5 Mg Q Am And 25 Mg Qpm; Total Daily Dose 37.5 Mg Oral, 12.5 Mg B Id Oral) was diagnosed with cerebral palsy, dystonia (What is dystonia?) and. Location: UNITED STATES , 18 years of age, After Xenazine was administered, patient had the following side effects: acute respiratory distress syndrome, alanine aminotransferase increased, aspartate aminotransferase increased, cholangitis acute, jaundice (What is jaundice?), pyrexia, vomiting. During the same period patient was treated with FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ), BACLOFEN (View Baclofen Review and Baclofen Label ), ATIVAN (View Ativan Review and Ativan Label ), PEPCID (View Pepcid Review and Pepcid Label ).

6864059-4 | Treatment Noncompliance
on Jul 12, 2010 Female patient from UNITED STATES , weighting 136.0 lb, was diagnosed with tardive dyskinesia and was treated with Xenazine (View Usage). Patient experienced the following unwanted or unexpected effects: treatment noncompliance. Xenazine dosage: 12.5 Mg Tid Oral. During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), COGENTIN (View Cogentin Review and Cogentin Label ), FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ), NAMENDA (View Namenda Review and Namenda Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), EXELON (View Exelon Review and Exelon Label ), SERTRALINE HYDROCHLORIDE (View Sertraline Hydrochloride Review and Sertraline Hydrochloride Label ).

6863470-5 | Disease Progression, Dyskinesia, Erythema, Huntington's Disease, Hypophagia, Weight Decreased
on Jul 09, 2010 Female patient from UNITED STATES , weighting 120.0 lb, was diagnosed with huntington's disease (What is huntington's disease?) and was treated with Xenazine (View Usage). Patient had the following side effects: disease progression, dyskinesia, erythema, huntington's disease (What is huntington's disease?), hypophagia, weight decreased. Xenazine dosage: (df Oral) (12.5 Mg Tid Oral), (12.5 Mg Qid Oral), (12.5 Mg Qd Oral).

6861407-6 | Apoptosis, Hyperkinesia, International Normalised Ratio Decreased, International Normalised Ratio Increased, Irritability, Williams Syndrome
Patient was taking Xenazine (View Usage). After Xenazine was administered, patient had the following side effects: apoptosis, hyperkinesia, international normalised ratio decreased, international normalised ratio increased, irritability, williams syndrome on Jul 08, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 30.00 lb, was diagnosed with chorea and. Xenazine dosage: (12.5 Mg Qd Oral), (1/2 Of 12.5 Mg Tablet Twice Daily Oral), (12.5 Mg Bid Oral). During the same period patient was treated with COUMADIN ((3 Mg And 3.5 Mg Tablets Alternating Days), (2.5 Mg Qd)) (View Coumadin Review and Coumadin Label ), RISPERIDONE (View Risperidone Review and Risperidone Label ), BACTRIM (View Bactrim Review and Bactrim Label ).

6782502-6 |
Adverse event was reported on Jun 07, 2010 by a Female patient taking Xenazine (View Usage) (Dosage: Df) was diagnosed with dystonia (What is dystonia?) and. Location: UNITED STATES , 45 years of age, . During the same period patient was treated with SABRIL (View Sabril Review and Sabril Label ).

6767649-2 | Chills, Dyspnoea, Lethargy, Parkinsonism
on Jun 03, 2010 Female patient from UNITED STATES , weighting 88.00 lb, was diagnosed with tardive dyskinesia and was treated with Xenazine (View Usage). Patient had the following side effects: chills, dyspnoea, lethargy, parkinsonism. Xenazine dosage: 12.5 Mg Qd Oral. During the same period patient was treated with DIAZEPAM (View Diazepam Review and Diazepam Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), LUNESTA (View Lunesta Review and Lunesta Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ).

6767116-6 |
on Jun 11, 2010 Female patient from UNITED STATES , 45 years of age, was treated with Xenazine (View Usage). . Xenazine dosage: .

6758717-X | Chest Pain, Dyspnoea
Patient was taking Xenazine (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), dyspnoea on May 21, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 159.0 lb, was diagnosed with tardive dyskinesia and. Xenazine dosage: 12.5 Mg Every Morning Oral, 12.5 Mg Bid Oral. During the same period patient was treated with CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), TERAZOSIN HCL (View Terazosin Hcl Review and Terazosin Hcl Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), BUPROPION HCL (View Bupropion Hcl Review and Bupropion Hcl Label ). Patient was hospitalized.

6753157-1 | Abdominal Pain, Condition Aggravated, Neuroleptic Malignant Syndrome, Non-cardiac Chest Pain
Adverse event was reported on May 24, 2010 by a Male patient taking Xenazine (View Usage) (Dosage: 25 Mg Qd Oral) was diagnosed with tourette's disorder and. Location: UNITED STATES , weighting 233.0 lb, Patient had the following side effects: abdominal pain (What is abdominal pain?), condition aggravated, neuroleptic malignant syndrome, non-cardiac chest pain. During the same period patient was treated with DEPAKOTE (View Depakote Review and Depakote Label ), CLOMIPRAMINE (View Clomipramine Review and Clomipramine Label ), HYDROXYZINE (View Hydroxyzine Review and Hydroxyzine Label ), PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ), FLUVOXAMINE MALEATE (View Fluvoxamine Maleate Review and Fluvoxamine Maleate Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), GEODON (View Geodon Review and Geodon Label ).

6735305-2 | Dystonia, Somnolence, Vomiting, Weight Increased
on May 12, 2010 Male patient from UNITED STATES , weighting 94.14 lb, was diagnosed with huntington's chorea, tic (What is tic?) and was treated with Xenazine (View Usage). After Xenazine was administered, patient had the following side effects: dystonia (What is dystonia?), somnolence, vomiting, weight increased. Xenazine dosage: See Image.

6732975-X | Abnormal Behaviour, Blood Pressure Increased, Condition Aggravated, Cyclic Vomiting Syndrome, Migraine, No Therapeutic Response, Refusal Of Treatment By Patient, Suicidal Ideation, Weight Increased
on May 05, 2010 Female patient from UNITED STATES , weighting 156.0 lb, was diagnosed with dyskinesia and was treated with Xenazine (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal behaviour, blood pressure increased, condition aggravated, cyclic vomiting syndrome, migraine (What is migraine?), no therapeutic response, refusal of treatment by patient, suicidal ideation, weight increased. Xenazine dosage: 25 Mg Qd, Oral, 12.5 Mg Qd, Oral. During the same period patient was treated with BACLOFEN (View Baclofen Review and Baclofen Label ), ZANAFLEX (View Zanaflex Review and Zanaflex Label ), FLEXERIL (View Flexeril Review and Flexeril Label ), XANAX (View Xanax Review and Xanax Label ), CHANTIX (View Chantix Review and Chantix Label ), AMBIEN (View Ambien Review and Ambien Label ), STADOL (View Stadol Review and Stadol Label ).

6719286-3 | Cardiac Disorder, Communication Disorder, Disease Complication, Drooling, Ecchymosis, Fall, Hyperreflexia, Motor Dysfunction, Posture Abnormal
Patient was taking Xenazine (View Usage). Patient had the following side effects: cardiac disorder, communication disorder, disease complication, drooling, ecchymosis, fall (What is fall?), hyperreflexia, motor dysfunction, posture abnormal on Apr 27, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 136.0 lb, was diagnosed with huntington's chorea and. Xenazine dosage: 25 Mg Tid Oral. During the same period patient was treated with ZYPREXA (5 Mb Bid And 10 Mg Qhs Oral, 2.5 Mg Bid And 10 Mg Qhs Oral) (View Zyprexa Review and Zyprexa Label ), DEPO PROVERA (View Depo-provera Review and Depo-provera Label ), ARICEPT (View Aricept Review and Aricept Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), NAMENDA (View Namenda Review and Namenda Label ), OXYTROL (View Oxytrol Review and Oxytrol Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ), TYLENOL (CAPLET) (View Tylenol (caplet) Review and Tylenol (caplet) Label ).

6719074-8 | Akathisia, Blepharospasm, Condition Aggravated, Constipation, Fatigue, Insomnia, Jaw Operation, Musculoskeletal Stiffness, Urine Output Decreased
Adverse event was reported on Apr 30, 2010 by a Female patient taking Xenazine (View Usage) (Dosage: 12.5 Mg Qd, Oral; 12.5 Mg Bid Oral, 12.5 Mg Tid Oral,12.5 Mg Bid Oral, 12.5 Mg Qd Oral) was diagnosed with chorea and. Location: UNITED STATES , weighting 162.0 lb, After Xenazine was administered, patient had the following side effects: akathisia, blepharospasm, condition aggravated, constipation (What is constipation?), fatigue, insomnia, jaw operation, musculoskeletal stiffness, urine output decreased. During the same period patient was treated with AVAPRO (View Avapro Review and Avapro Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), LIPITOR (View Lipitor Review and Lipitor Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ).

6676576-0 | Areflexia, Blood Chloride Decreased, Blood Glucose Increased, Blood Potassium Decreased, Blood Pressure Decreased, Blood Sodium Decreased, Body Temperature Increased, Cardiac Arrest, Coma
on Mar 30, 2010 Male patient from UNITED STATES , weighting 125.0 lb, was diagnosed with dystonia (What is dystonia?) and was treated with Xenazine (View Usage). Patient experienced the following unwanted or unexpected effects: areflexia, blood chloride decreased, blood glucose increased, blood potassium decreased, blood pressure decreased, blood sodium decreased, body temperature increased, cardiac arrest (What is cardiac arrest?), coma. Xenazine dosage: See Image, Oral. During the same period patient was treated with DANTRIUM (View Dantrium Review and Dantrium Label ), TIZANIDINE HCL (View Tizanidine Hcl Review and Tizanidine Hcl Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ). Patient was hospitalized.

6669137-0 | Agitation, Confusional State, Hallucination, Visual
on Mar 29, 2010 Female patient from UNITED STATES , weighting 180.8 lb, was diagnosed with chorea, urinary tract infection (What is urinary tract infection?) and was treated with Xenazine (View Usage). Patient had the following side effects: agitation, confusional state, hallucination, visual. Xenazine dosage: See Image. During the same period patient was treated with BACTRIM (View Bactrim Review and Bactrim Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ).

6657222-9 | Headache, Nausea, Retching
Patient was taking Xenazine (View Usage). After Xenazine was administered, patient had the following side effects: headache (What is headache?), nausea (What is nausea?), retching on Oct 27, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 138.0 lb, was diagnosed with obsessive-compulsive disorder (What is obsessive-compulsive disorder?) and. Xenazine dosage: See Image. During the same period patient was treated with PROZAC (View Prozac Review and Prozac Label ), AMBIEN (View Ambien Review and Ambien Label ), MELATONIN (View Melatonin Review and Melatonin Label ), PRIMIDONE (View Primidone Review and Primidone Label ).

6657198-4 | Insomnia, Muscle Twitching
Adverse event was reported on Nov 17, 2009 by a Female patient taking Xenazine (View Usage) (Dosage: 12.5 Mg Qd Oral) was diagnosed with muscle twitching and. Location: UNITED STATES , weighting 144.0 lb, Patient experienced the following unwanted or unexpected effects: insomnia, muscle twitching. During the same period patient was treated with ALTACE (View Altace Review and Altace Label ), PROTONIX (View Protonix Review and Protonix Label ), CELEXA (View Celexa Review and Celexa Label ), MAXZIDE (View Maxzide Review and Maxzide Label ), LOVAZA (View Lovaza Review and Lovaza Label ), M.V.I. (View M.v.i. Review and M.v.i. Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), CALAN (View Calan Review and Calan Label ).

6656731-6 | Ataxia, Confusional State, Cough, Feeding Disorder, Gait Disturbance, Headache, Irritability, Pneumonia, Pyrexia
on Mar 16, 2010 Male patient from UNITED STATES , weighting 128.0 lb, was diagnosed with tardive dyskinesia and was treated with Xenazine (View Usage). Patient had the following side effects: ataxia (What is ataxia?), confusional state, cough, feeding disorder, gait disturbance, headache (What is headache?), irritability, pneumonia (What is pneumonia?), pyrexia. Xenazine dosage: 12.5 Mg Qd Oral, 12.5 Mg Bid Oral. During the same period patient was treated with BENAZEPRIL HYDROCHLORIDE (View Benazepril Hydrochloride Review and Benazepril Hydrochloride Label ), DILTIAZEM HCL (View Diltiazem Hcl Review and Diltiazem Hcl Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), BUPROPION HCL (View Bupropion Hcl Review and Bupropion Hcl Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), DEPAKOTE (View Depakote Review and Depakote Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ). Patient was hospitalized.

6655117-8 | Somnolence
on Jan 28, 2010 Female patient from UNITED STATES , weighting 132.0 lb, was diagnosed with huntington's chorea and was treated with Xenazine (View Usage). After Xenazine was administered, patient had the following side effects: somnolence. Xenazine dosage: 12.5 Mg Bid Oral, 12.5 Mg Qd Oral, 12.5 Mg Tid Oral. During the same period patient was treated with CYMBALTA (View Cymbalta Review and Cymbalta Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), DEPAKOTE (View Depakote Review and Depakote Label ), ADDERALL 30 (View Adderall 30 Review and Adderall 30 Label ), TRAZODONE (View Trazodone Review and Trazodone Label ), LUMIGAN (View Lumigan Review and Lumigan Label ).

6637809-X | Abnormal Behaviour, Agitation, Confusional State, Hallucination, Visual
Patient was taking Xenazine (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal behaviour, agitation, confusional state, hallucination, visual on Mar 04, 2010 from UNITED STATES Additional patient health information: Female patient , 89 years of age, was diagnosed with chorea, urinary tract infection (What is urinary tract infection?) and. Xenazine dosage: 150 Mg Total Daily Dose Oral 25 Mg Qid Oral. During the same period patient was treated with BACTRIM (Df) (View Bactrim Review and Bactrim Label ).

6625859-9 | Dyspnoea, Failure To Thrive, Hypotension, Respiratory Rate Increased
Adverse event was reported on Feb 23, 2010 by a Female patient taking Xenazine (View Usage) (Dosage: (12.5 Mg Bid), (12.5 Mg Tid)) was diagnosed with huntington's chorea and. Location: UNITED STATES , weighting 98.00 lb, Patient had the following side effects: dyspnoea, failure to thrive, hypotension, respiratory rate increased. During the same period patient was treated with ROXANOL (NOT SPECIFIED) ((30 Ml (20 Mg/1 Ml))) (View Roxanol (not Specified) Review and Roxanol (not Specified) Label ), MORPHINE SULFATE ((5mg Bid Sublingual)) (View Morphine Sulfate Review and Morphine Sulfate Label ).

6621912-4 | Convulsion, Dystonia, Somnolence
on Feb 25, 2010 Male patient from UNITED STATES , weighting 94.14 lb, was diagnosed with tic (What is tic?) and was treated with Xenazine (View Usage). After Xenazine was administered, patient had the following side effects: convulsion, dystonia (What is dystonia?), somnolence. Xenazine dosage: See Image. During the same period patient was treated with MULTIVITAMIN /00831701/ (View Multivitamin /00831701/ Review and Multivitamin /00831701/ Label ), KEPPRA (View Keppra Review and Keppra Label ).

6619222-4 | Blood Albumin Decreased, Blood Urea Increased, Bursitis, Cellulitis Staphylococcal, Cellulitis Streptococcal, Depression, Joint Swelling, Lethargy, Pneumonia Aspiration
on Feb 22, 2010 Male patient from UNITED STATES , weighting 116.0 lb, was diagnosed with cerebral palsy, choreoathetosis, quadriplegia and was treated with Xenazine (View Usage). Patient experienced the following unwanted or unexpected effects: blood albumin decreased, blood urea increased, bursitis (What is bursitis?), cellulitis staphylococcal, cellulitis streptococcal, depression (What is depression?), joint swelling, lethargy, pneumonia aspiration. Xenazine dosage: (df Oral), (25 Mg Tid Oral), (12.5 Mg Bid Oral) , (12.5 Mg Tid Oral). During the same period patient was treated with RISPERDAL (View Risperdal Review and Risperdal Label ), ARICEPT (View Aricept Review and Aricept Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), ATIVAN (View Ativan Review and Ativan Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ). Patient was hospitalized.

6619203-0 | Dystonia, Somnolence
Patient was taking Xenazine (View Usage). Patient had the following side effects: dystonia (What is dystonia?), somnolence on Feb 22, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 90.83 lb, was diagnosed with tic (What is tic?) and. Xenazine dosage: See Image. During the same period patient was treated with MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), COGENTIN (View Cogentin Review and Cogentin Label ), KEPPRA (View Keppra Review and Keppra Label ).

6613137-3 | Blood Pressure Increased, Chest Discomfort, Chest Pain, Disease Recurrence, Dyskinesia, Electrocardiogram Abnormal, Somnolence
Adverse event was reported on Feb 17, 2010 by a Female patient taking Xenazine (View Usage) (Dosage: 12.5 Mg Qd Oral) was diagnosed with chorea and. Location: UNITED STATES , weighting 130.0 lb, After Xenazine was administered, patient had the following side effects: blood pressure increased, chest discomfort, chest pain (What is chest pain?), disease recurrence, dyskinesia, electrocardiogram abnormal, somnolence. During the same period patient was treated with CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), RITALIN (View Ritalin Review and Ritalin Label ). Patient was hospitalized.

6599836-0 | Aggression, Anger, Personality Change
on Feb 05, 2010 Male patient from UNITED STATES , 52 years of age, was diagnosed with tourette's disorder and was treated with Xenazine (View Usage). Patient experienced the following unwanted or unexpected effects: aggression, anger, personality change. Xenazine dosage: (50 Mg Bid). During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ), METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), COMBIVENT (View Combivent Review and Combivent Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), DOCUSATE (View Docusate Review and Docusate Label ).

6595239-3 | Pneumonia
on Jan 28, 2010 Male patient from UNITED STATES , 56 years of age, was diagnosed with huntington's chorea and was treated with Xenazine (View Usage). Patient had the following side effects: pneumonia (What is pneumonia?). Xenazine dosage: 37.5 Mg Bid, (1.5 Tablets Of 25 Mg Twice A Daily) Oral).

6591170-8 | Blood Pressure Increased, Chest Discomfort, Electrocardiogram Abnormal
Patient was taking Xenazine (View Usage). After Xenazine was administered, patient had the following side effects: blood pressure increased, chest discomfort, electrocardiogram abnormal on Feb 03, 2010 from UNITED STATES Additional patient health information: Female patient , 61 years of age, was diagnosed with dyskinesia, extrapyramidal disorder and. Xenazine dosage: (12.5 Mg Qd Oral). During the same period patient was treated with CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), RITALIN (View Ritalin Review and Ritalin Label ). Patient was hospitalized.

6582702-4 | Anxiety, Condition Aggravated, Decreased Appetite, Depression, Insomnia, Oedema Peripheral, Respiratory Disorder, Somnolence
Adverse event was reported on Jan 25, 2010 by a Female patient taking Xenazine (View Usage) (Dosage: See Image) was diagnosed with essential tremor and. Location: UNITED STATES , weighting 119.0 lb, Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), condition aggravated, decreased appetite, depression (What is depression?), insomnia, oedema peripheral, respiratory disorder, somnolence. During the same period patient was treated with PRIMIDONE ((250 Mg Qd), (1/2 Tablet Hs)) (View Primidone Review and Primidone Label ), PROPRANOLOL HYDROCHLORIDE ((120 Mg Bid)) (View Propranolol Hydrochloride Review and Propranolol Hydrochloride Label ), TRAZODONE HCL ((q Hs)) (View Trazodone Hcl Review and Trazodone Hcl Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ).

6566807-X | Aggression, Blood Sodium Increased, Blood Urea Increased, Cognitive Disorder, Condition Aggravated, Convulsion, Dysphagia, Hypophagia, Lethargy
on Dec 11, 2009 Female patient from UNITED STATES , weighting 106.0 lb, was diagnosed with huntington's chorea and was treated with Xenazine (View Usage). Patient had the following side effects: aggression, blood sodium increased, blood urea increased, cognitive disorder, condition aggravated, convulsion, dysphagia, hypophagia, lethargy. Xenazine dosage: 25 Mg Bid Oral, 25 Mg Bid Oral (df). During the same period patient was treated with ATIVAN (View Ativan Review and Ativan Label ), CHLORHEXIDINE GLUCONATE (View Chlorhexidine Gluconate Review and Chlorhexidine Gluconate Label ), CALCIUM WITH VITAMIN D (View Calcium With Vitamin D Review and Calcium With Vitamin D Label ), MULTIVITAMIN /01229101/ (View Multivitamin /01229101/ Review and Multivitamin /01229101/ Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), VITAMIN E (View Vitamin E Review and Vitamin E Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ). Patient was hospitalized.

6558268-1 | Agitation, Belligerence
on Jan 19, 2010 Male patient from UNITED STATES , 45 years of age, was diagnosed with huntington's chorea and was treated with Xenazine (View Usage). After Xenazine was administered, patient had the following side effects: agitation, belligerence. Xenazine dosage: Df.

6530475-3 | Aphasia, Condition Aggravated, Dyskinesia
Patient was taking Xenazine (View Usage). Patient experienced the following unwanted or unexpected effects: aphasia (What is aphasia?), condition aggravated, dyskinesia on Jan 06, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 200.0 lb, was diagnosed with ballismus, hemiparesis, tremor and. Xenazine dosage: 1 Dose 4 Weeks; 2 Dose 2 Weeks.

6523064-8 | Cognitive Disorder, Convulsion, Dysphagia, Lethargy, Pharyngitis, Pneumonia, Weight Decreased
Adverse event was reported on Dec 11, 2009 by a Female patient taking Xenazine (View Usage) (Dosage: 25 Mg Bid Oral, 25 Mg Bid Oral, Df) was diagnosed with huntington's chorea and. Location: UNITED STATES , weighting 106.0 lb, Patient had the following side effects: cognitive disorder, convulsion, dysphagia, lethargy, pharyngitis, pneumonia (What is pneumonia?), weight decreased. During the same period patient was treated with CHLORHEXIDIEN GLUCONATE (View Chlorhexidien Gluconate Review and Chlorhexidien Gluconate Label ), COENZYME Q10 (View Coenzyme Q10 Review and Coenzyme Q10 Label ), DIVALPROXE SODIUM (View Divalproxe Sodium Review and Divalproxe Sodium Label ), HALOPERIDOL LACTATE (View Haloperidol Lactate Review and Haloperidol Lactate Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), FRUITE PASTE (View Fruite Paste Review and Fruite Paste Label ). Patient was hospitalized and became disabled.

6522369-4 | Cognitive Disorder, Dementia, Incontinence, Movement Disorder
on Dec 08, 2009 Female patient from UNITED STATES , 75 years of age, was diagnosed with tardive dyskinesia and was treated with Xenazine (View Usage). After Xenazine was administered, patient had the following side effects: cognitive disorder, dementia (What is dementia?), incontinence, movement disorder (What is movement disorder?). Xenazine dosage: 50 Mg Bid.

6466078-9 | Somnolence
on Nov 19, 2009 Male patient from UNITED STATES , weighting 132.3 lb, was diagnosed with huntington's chorea, movement disorder (What is movement disorder?) and was treated with Xenazine (View Usage). Patient experienced the following unwanted or unexpected effects: somnolence. Xenazine dosage: See Image.

6433084-X | Cardiac Failure Congestive, Dehydration, Diarrhoea, Dyspnoea, Malnutrition
Patient was taking Xenazine (View Usage). Patient had the following side effects: cardiac failure congestive, dehydration, diarrhoea, dyspnoea, malnutrition on Oct 28, 2009 from UNITED STATES Additional patient health information: Female patient , 73 years of age, was diagnosed with huntington's chorea and. Xenazine dosage: (12.5 Mg Qd Oral). During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ISORDIL (View Isordil Review and Isordil Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), IMODIUM /00384302 (View Imodium /00384302 Review and Imodium /00384302 Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), MICARDIS (View Micardis Review and Micardis Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ATENOLOL (View Atenolol Review and Atenolol Label ). Patient was hospitalized.